Pricing Log in Create free account

Kailera Therapeutics, Inc. (KLRA) vs Nanobiotix S.A. - Sponsored ADR (NBTX)

Kailera Therapeutics, Inc. and Nanobiotix S.A. - Sponsored ADR are both Biotechnology companies. Kailera Therapeutics, Inc. and Nanobiotix S.A. - Sponsored ADR are of similar size ($1.6B and $1.5B). Across the 7 metrics below, Nanobiotix S.A. - Sponsored ADR leads on 4 and Kailera Therapeutics, Inc. on 3.

Valuation

Metric KLRA NBTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 6,111.93 9.40
P/B 1.63 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 5,356.43 9.02
Earnings yield 661,008,480.09% (10.85%) (32.88%)
Free cash flow yield (19.39%) (13.68%) (23.13%)

Profitability

Metric KLRA NBTX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (85.74%) 0.00% (51.96%)
Return on assets (55.25%) 0.00% (46.06%)
Return on invested capital (182.92%) 0.00% 0.00%

Growth

Metric KLRA NBTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) — 63.46% 29.88%
Revenue growth, 5-year CAGR — 66.64% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric KLRA NBTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 21.84 1.44 4.97
Net debt to EBITDA 3.46 5.66 1.01

Dividend

Metric KLRA NBTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric KLRA NBTX Biotechnology median
Market cap 1.58b 1.53b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack